Hooman Soleymani majd

I started my Obstetrics and Gynaecology career in London, before moving to Oxford and completing my structured postgraduate training programme. During the course of training I obtained membership of the Royal College of Obstetricians and Gynaecologists (MRCOG), which culminated in a Certificate of Completion of Training (CCT) in Obstetrics and Gynaecology. I then completed a further three years of Sub-Specialty Training in Gynaecological Oncology at the Churchill Cancer Centre in Oxford. I am a BSCCP accredited Colposcopist and trainer, a member of the British Gynaecological Cancer Society (BGCS) and the European Society of Gynaecology Oncology (ESGO). I am a Consultant in Gynaecological Oncology at the Churchill Hospital and have been in post since 2016. I am a visiting Professor at the prestigious Guangxi Medical University Cancer Centre in Nanning, CHINA.

I have a special interest in developing new surgical techniques in ultra-radical surgery for advanced ovarian cancer and radical pelvic exenteration operations. My skill set includes upper abdominal surgery, liver mobilisation and diaphragmatic reconstruction. I also have a particular interest in treating patients with Placenta Accreta Spectrum (PAS). I am a founding member and surgical lead for the OxPAT group. I am also a member of the Oxford Sarcoma team.

I am currently collaborating with Professor Sarosh Irani in the Nuffield Department of Clinical Neurosciences and Dr Adam Al-Diwani in the department of psychiatry on auto-antibody mediated neurological diseases. 

I am actively involved in teaching registrars/fellows and medical students from Oxford University. I have published numerous papers and been an invited speaker at a number of international congresses. I am on the editorial board of Current Problems in Cancer: Case Reports, Gynecology and Pelvic Medicine (GPM) and the Journal of Obstetrics, Gynecology and Cancer Research (JOGCR). I am also a reviewer for Cereus, BMJ case reports, European Journal of Gynaecology Oncology (EJGO) and Frontiers in Oncology.